Italian competition body probes pricing in the vaccines market
This article was originally published in Scrip
Executive Summary
The Italian competition authority (AGCM) has launched a sector inquiry into the human vaccines market with a view to examining how public tenders are run and whether some companies are involved in "excessive" pricing or other anticompetitive practices.